The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]

+ References

+ Details

Name:	ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represent the fair value per share option.

+ References

No definition available.

+ Details

Name:	ifrx_FairValuePerShareOption
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The foreign exchange rate as grant date.

+ References

No definition available.

+ Details

Name:	ifrx_ForeignExchangeRateAsOfGrantDate
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Share options granted options.

+ References

No definition available.

+ Details

Name:	ifrx_ShareOptionsGrantedOptions
Namespace Prefix:	ifrx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The share price at grant date and exercise price.

+ References

No definition available.

+ Details

Name:	ifrx_SharePriceAtGrantDateExercisePrices
Namespace Prefix:	ifrx_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_MayThirtyOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulyNineteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_SeptemberEighteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_FebruaryTwentyOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_OctoberThirtyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Consolidated Statements of Operations and Comprehensive Loss - Schedule of Weighted Average (Details)	12 Months Ended
	Dec. 31, 2025 € / shares $ / shares shares	Dec. 31, 2024 € / shares $ / shares shares	Dec. 31, 2023 € / shares $ / shares shares	Dec. 31, 2025 $ / shares	Dec. 31, 2024 $ / shares	Dec. 31, 2023 $ / shares
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares	2,452,000	2,332,500	1,735,750
January 24 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			1,454,250
Fair value per share option \| (per share)			€ 1.9			$ 2.11
FX rate as of grant date			€ 0.9008
Share price at grant date/ Exercise price			€ 2.37
Expected volatility			1.35%
Expected life (midpoint based)			5 years 3 months 18 days
Risk-free rate (interpolated, U.S. sovereign strips curve)			3.571%
January 24 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			52,500
Fair value per share option \| (per share)			€ 1.92			2.13
FX rate as of grant date			€ 0.9008
Share price at grant date/ Exercise price			€ 2.37
Expected volatility			1.35%
Expected life (midpoint based)			5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			3.565%
May 31 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			60,500
Fair value per share option \| (per share)			€ 3.38			3.61
FX rate as of grant date			€ 0.9361
Share price at grant date/ Exercise price			€ 4.19
Expected volatility			1.35%
Expected life (midpoint based)			4 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			3.82%
July 7 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			57,000
Fair value per share option \| (per share)			€ 3.3			3.59
FX rate as of grant date			€ 0.9184
Share price at grant date/ Exercise price			€ 3.89
Expected volatility			1.46%
Expected life (midpoint based)			5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			4.32%
July 7 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			100,000
Fair value per share option \| (per share)			€ 3.34			3.64
FX rate as of grant date			€ 0.9184
Share price at grant date/ Exercise price			€ 3.89
Expected volatility			1.46%
Expected life (midpoint based)			6 years 1 month 6 days
Risk-free rate (interpolated, U.S. sovereign strips curve)			4.286%
July 19 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			4,000
Fair value per share option \| (per share)			€ 3.16			3.55
FX rate as of grant date			€ 0.8911
Share price at grant date/ Exercise price			€ 3.99
Expected volatility			1.46%
Expected life (midpoint based)			5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			4.32%
September 18 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares			7,500
Fair value per share option \| (per share)			€ 2.95			$ 3.15
FX rate as of grant date			€ 0.9378
Share price at grant date/ Exercise price			€ 3.54
Expected volatility			1.46%
Expected life (midpoint based)			5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)			4.32%
January 05 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares		2,245,000
Fair value per share option \| (per share)		€ 1.51			$ 1.65
FX rate as of grant date		€ 0.916
Share price at grant date/ Exercise price		€ 1.79
Expected volatility		1.47%
January 05 [Member] \| Bottom of range [Member]
Schedule of Weighted Average [Line Items]
Expected life (midpoint based)		5 years 3 months 18 days
Risk-free rate (interpolated, U.S. sovereign strips curve)		4.023%
January 05 [Member] \| Top of range [Member]
Schedule of Weighted Average [Line Items]
Expected life (midpoint based)		5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)		4.025%
February 21 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares		30,000
Fair value per share option \| (per share)		€ 1.3			1.4
FX rate as of grant date		€ 0.925
Share price at grant date/ Exercise price		€ 1.51
Expected volatility		1.47%
Expected life (midpoint based)		5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)		4.308%
October 30 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares		57,500
Fair value per share option \| (per share)		€ 1.33			$ 1.44
FX rate as of grant date		€ 0.9246
Share price at grant date/ Exercise price		€ 1.57
Expected volatility		1.43%
Expected life (midpoint based)		5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)		4.155%
January 03 [Member]
Schedule of Weighted Average [Line Items]
Options (in Shares) \| shares	2,452,000
Fair value per share option \| (per share)	€ 1.81			$ 1.86
FX rate as of grant date	€ 0.971
Share price at grant date/ Exercise price	€ 2.41
Expected volatility	0.97%
Expected life (midpoint based)	5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve)	4.435%